| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | DENOVX, LLC | 3440 S DEARBORN ST STE 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 3 | NIH | 3/11/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $349,999 ) |
| | 2024 | 2024 | DENOVX, LLC | 3440 S DEARBORN ST STE 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R43GM156151 | Improving Cryo-EM Specimen Quality Using Surface Science | 000 | 1 | NIH | 9/18/2024 | $349,999 |
|
| Issue Date FY: 2023 ( Subtotal = $711,255 ) |
| | 2023 | 2023 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44DA047146 | Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders | 000 | 3 | NIH | 8/9/2023 | $711,255 |
| | 2023 | 2021 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R43GM140508 | Microfluidic Protein Flow Crystallization Using Engineered Nucleation Features for Serial and Traditional Crystallography | 000 | 1 | NIH | 9/26/2023 | $0 |
| | 2023 | 2021 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 3 | NIH | 5/23/2023 | $0 |
| | 2023 | 2020 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 3 | NIH | 3/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,775,613 ) |
| | 2022 | 2022 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44DA047146 | Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders | 000 | 2 | NIH | 9/20/2022 | $1,775,613 |
| | 2022 | 2020 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 3 | NIH | 11/5/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,225,261 ) |
| | 2021 | 2021 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R43GM140508 | Microfluidic Protein Flow Crystallization Using Engineered Nucleation Features for Serial and Traditional Crystallography | 000 | 1 | NIH | 7/21/2021 | $313,184 |
| | 2021 | 2021 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 3 | NIH | 7/26/2021 | $912,077 |
| | 2021 | 2018 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 3 | NIH | 7/2/2021 | $0 |
| | 2021 | 2018 | DENOVX, LLC | 3440 S DEARBORN ST # 204-S | CHICAGO | IL | 60616-5074 | COOK | USA | R43DA047146 | Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders | 000 | 1 | NIH | 11/17/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,747,436 ) |
| | 2020 | 2020 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 2 | NIH | 7/30/2020 | $1,078,661 |
| | 2020 | 2020 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 3 | NIH | 3/2/2020 | $668,775 |
| | 2020 | 2018 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 3 | NIH | 8/13/2020 | $0 |
| | 2020 | 2018 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 001 | 3 | NIH | 8/13/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $800,139 ) |
| | 2019 | 2019 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 2 | NIH | 2/20/2019 | $800,139 |
|
| Issue Date FY: 2018 ( Subtotal = $1,297,536 ) |
| | 2018 | 2018 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 3 | NIH | 8/28/2018 | $860,896 |
| | 2018 | 2018 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R43DA047146 | Advanced Nucleation Technologies for Membrane Protein Crystallization to Accelerate Structure-Based Drug Design for Substance Use Disorders | 000 | 1 | NIH | 6/14/2018 | $349,515 |
| | 2018 | 2018 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 001 | 3 | NIH | 8/29/2018 | $87,125 |
| | 2018 | 2016 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R43TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 1 | NIH | 2/2/2018 | $0 |
| | 2018 | 2016 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R43GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 1 | NIH | 5/7/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $930,985 ) |
| | 2017 | 2017 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R44GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 2 | NIH | 8/10/2017 | $930,985 |
| | 2017 | 2015 | DENOVX, LLC | 651 S. SUTTON RD., STE. 300 | STREAMWOOD | IL | 60107-2366 | COOK | USA | R43GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 1 | NIH | 11/4/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $536,386 ) |
| | 2016 | 2016 | DENOVX, LLC | DENOVX, LLC | STREAMWOOD | IL | 60107 | COOK | USA | R43TR001380 | Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages | 000 | 1 | NIH | 3/24/2016 | $224,854 |
| | 2016 | 2016 | DENOVX, LLC | DENOVX, LLC | STREAMWOOD | IL | 60107 | COOK | USA | R43GM116285 | Multiplexed Nucleation Approaches for Enhanced High Throughput Screening of Co-Crystals | 000 | 1 | NIH | 4/29/2016 | $311,532 |
|
| Issue Date FY: 2015 ( Subtotal = $223,915 ) |
| | 2015 | 2015 | DENOVX, LLC | DENOVX, LLC | STREAMWOOD | IL | 60107 | COOK | USA | R43GM108158 | Microdomain Thermal Perturbations for Enhanced Nucleation of Proteins | 000 | 1 | NIH | 1/9/2015 | $223,915 |
|
|
